Recombitek Lyme - 2126.R0
2,012 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
2,012
Total Reports
21
Deaths Reported
100.0%
Death Rate
Active Ingredients
Recombitek Lyme - 2126.R0
Administration Routes
SubcutaneousUnknownSubconjunctivalIntramuscularDentalOral
Species Affected
Dog 2,011
Horse 1
Most Affected Breeds
Retriever - Labrador 356
Retriever - Golden 221
Shepherd Dog - German 122
Shepherd Dog - Australian 96
Crossbred Canine/dog 82
Mountain Dog - Bernese 70
Beagle 63
Collie - Border 45
Siberian Husky 38
Boxer (German Boxer) 37
Most Reported Reactions
Lack of efficacy (bacteria) - Borrelia 1,246
Lack of efficacy (ectoparasite) - tick NOS 701
Lack of efficacy (bacteria) - NOS 575
Lack of efficacy (tick) 446
Lack of efficacy (bacteria) - Anaplasma 82
Vomiting 66
Lethargy (see also Central nervous system depression in 'Neurological') 49
Diarrhoea 40
Systemic disorder NOS 35
Drug dose omission 35
Other abnormal test result NOS 34
Underdose 24
Outcome Breakdown
Outcome Unknown
1,393 (69.2%)
Ongoing
509 (25.3%)
Recovered/Normal
81 (4.0%)
Euthanized
15 (0.7%)
Recovered with Sequela
10 (0.5%)
Died
6 (0.3%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.